EDGAR Filing Documents for 0001193125-09-148099

Form 8-K - Current report:

SEC Accession No. 0001193125-09-148099

Filing Date

2009-07-13

Accepted

2009-07-13 15:40:27

Documents

Period of Report

2009-07-08

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d8k.htm	8-K	27935
2	EXECUTIVE CHANGE IN CONTROL SEVERANCE BENEFIT PLAN, AMENDED AS OF JULY 8, 2009	dex101.htm	EX-10.1	87947
3	CHANGE IN CONTROL SEVERANCE BENEFIT PLAN, AMENDED AS OF JULY 8, 2009	dex102.htm	EX-10.2	79257
4	AMENDED 2005 EQUITY COMPENSATION PLAN, AS AMENDED EFFECTIVE JULY 8,2009	dex103.htm	EX-10.3	78592
5	FORM OF 1995 STOCK PLAN NONQUALIFIED STOCK OPTION GRANT AGREEMENT	dex104.htm	EX-10.4	41053
6	FORM OF RESTRICTED STOCK UNIT AGREEMENT	dex105.htm	EX-10.5	20323
7	FORM OF 1995 STOCK PLAN DIRECTOR'S NONQUALIFIED STOCK OPTION GRANT AGREEMENT	dex106.htm	EX-10.6	41732
8	FORM OF 2005 EQUITY COMPENSATION PLAN DIRECTOR'S NONQUALIFIED STOCK OPTION GRANT	dex107.htm	EX-10.7	36604
	Complete submission text file	0001193125-09-148099.txt		415108

Mailing Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466

Business Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466 9199419777

INSPIRE PHARMACEUTICALS INC (Filer) CIK: 0001040416 (see all company filings)